47 related articles for article (PubMed ID: 31366479)
1. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
Dvorská D; Škovierová H; Braný D; Halašová E; Danková Z
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387281
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of MRI in the differential diagnosis between uterine leiomyomas and sarcomas: A systematic review and meta-analysis.
Raffone A; Raimondo D; Neola D; Travaglino A; Giorgi M; Lazzeri L; De Laurentiis F; Carravetta C; Zupi E; Seracchioli R; Casadio P; Guida M
Int J Gynaecol Obstet; 2024 Apr; 165(1):22-33. PubMed ID: 37732472
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of Ultrasound in the Diagnosis of Uterine Leiomyomas and Sarcomas.
Raffone A; Raimondo D; Neola D; Travaglino A; Raspollini A; Giorgi M; Santoro A; De Meis L; Zannoni GF; Seracchioli R; Casadio P; Guida M
J Minim Invasive Gynecol; 2024 Jan; 31(1):28-36.e1. PubMed ID: 37778636
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract][Full Text] [Related]
5. Olaratumab-induced Biomarker Modulation in Sarcomas-Response.
Martín-Broto J; Peterson PM; Oakley GJ; Ceccarelli M; Jones RL
Mol Cancer Ther; 2021 Oct; 20(10):2094. PubMed ID: 34607902
[No Abstract] [Full Text] [Related]
6. Benign uterine mass-discrimination from leiomyosarcoma by a preoperative risk score: a multicenter cohort study.
Köhler G; Vollmer M; Nath N; Hessler PA; Dennis K; Lehr A; Köller M; Riechmann C; Bralo H; Trojnarska D; Lehnhoff H; Krichbaum J; Krichbaum M; Evert K; Evert M; Zygmunt M; Kaderali L
Arch Gynecol Obstet; 2019 Dec; 300(6):1719-1727. PubMed ID: 31677088
[TBL] [Abstract][Full Text] [Related]
7. Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels.
Suzuki A; Kido A; Matsuki M; Kotani Y; Murakami K; Yamanishi Y; Numoto I; Nakai H; Otani T; Konishi I; Mandai M; Matsumura N
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189505
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.
Żak K; Zaremba B; Rajtak A; Kotarski J; Amant F; Bobiński M
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454875
[TBL] [Abstract][Full Text] [Related]
9. Metabolic landscapes in sarcomas.
Miallot R; Galland F; Millet V; Blay JY; Naquet P
J Hematol Oncol; 2021 Jul; 14(1):114. PubMed ID: 34294128
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Blood Inflammatory Markers for the Differentiation of Uterine Leiomyosarcoma from Leiomyoma.
Suh DS; Song YJ; Roh HJ; Lee SH; Jeong DH; Lee TH; Choi KU; Kim KH
Cancer Manag Res; 2021; 13():5001-5011. PubMed ID: 34211296
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System.
Zhang F; Liu Y; Quan Q; Meng Y; Mu X
Cancer Manag Res; 2021; 13():4657-4664. PubMed ID: 34163240
[TBL] [Abstract][Full Text] [Related]
12. Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
De Wispelaere W; Annibali D; Tuyaerts S; Lambrechts D; Amant F
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922556
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in Uterine Sarcoma.
Jeong MJ; Park JH; Hur SY; Kim CJ; Nam HS; Lee YS
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32911724
[TBL] [Abstract][Full Text] [Related]
14. Circulating Protein Biomarkers to Differentiate Uterine Sarcomas from Leiomyomas.
Glorie N; Baert T; VAN DEN Bosch T; Coosemans AN
Anticancer Res; 2019 Aug; 39(8):3981-3989. PubMed ID: 31366479
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel and rapid measurement system for growth differentiation factor-15, progranulin, and osteopontin in uterine sarcoma.
Maeno M; Mizutani T; Tsuyoshi H; Yamada S; Ishikane S; Kawabe S; Nishimura K; Yamada M; Miyamoto K; Yoshida Y
Endocr J; 2020 Jan; 67(1):91-94. PubMed ID: 31534059
[TBL] [Abstract][Full Text] [Related]
17. Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?
De Bruyn C; Baert T; Van den Bosch T; Coosemans A
Curr Oncol Rep; 2020 Jan; 22(2):12. PubMed ID: 31997106
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
